Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia

Convalescent plasma (CP) has been the first line of defense against numerous infectious diseases throughout history. The COVID-19 pandemic created a need for a quick, easily accessible, and effective treatment for severe disease and CP was able to meet that immediate need. The utility of CP warrants...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, Jennifer L., Palat, David S., Subik, M. Kristina, Lee, William T., McDonough, Kathleen A., Conuel, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907110/
http://dx.doi.org/10.1016/j.clicom.2022.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907110/
http://dx.doi.org/10.1016/j.clicom.2022.03.001

Ejemplares similares